Daruvir 600 Mg Tablets

Daruvir 600 Mg Tablets

उत्पाद विवरण:

  • दवा का प्रकार
  • भौतिक रूप
  • के लिए सुझाया गया Doctor
  • खुराक संबंधी दिशा-निर्देश As per Instructions
  • के लिए उपयुक्त
  • स्टोरेज निर्देश Cool & Dry Place
  • Click to view more
X

मूल्य और मात्रा

  • 2

उत्पाद की विशेषताएं

  • Doctor
  • Cool & Dry Place
  • As per Instructions

व्यापार सूचना

  • , ,
  • प्रति सप्ताह
  • दिन
  • No
  • , , , , , , , ,

उत्पाद विवरण

1. Technical Specifications

Attribute Details
Brand Name Daruvir-R Tablet
Generic Name Darunavir + Ritonavir
Strength Darunavir 600 mg + Ritonavir 100 mg per tablet
Dosage Form Oral Tablet
Packaging Size Commonly 60 tablets per bottle
Packaging Type HDPE bottle with child-resistant cap
Medicine Type Antiretroviral (Protease Inhibitor + Pharmacokinetic Booster)
Manufacturer Cipla Ltd.
Distributed By Authorized antiretroviral drug distributors / pharmacies

2. Product Description

Daruvir-R Tablet is a fixed-dose combination of Darunavir (600 mg) and Ritonavir (100 mg).

  • Darunavir is a protease inhibitor that prevents HIV protease enzyme from cleaving viral polyproteins, leading to production of immature, non-infectious viral particles.

  • Ritonavir acts as a pharmacokinetic enhancer (booster) by inhibiting CYP3A4 metabolism, thereby increasing plasma concentration and efficacy of Darunavir.

It is indicated for the treatment of HIV-1 infection in adults and adolescents, usually in combination with other antiretroviral agents.


3. Product Highlights

Attribute Details
Therapeutic Category Antiretroviral Protease Inhibitor Combination
Application Area Management of HIV-1 infection
Mechanism of Action Darunavir inhibits HIV-1 protease blocks viral replication; Ritonavir boosts Darunavir plasma levels by CYP3A4 inhibition
Administration Oral; usually one tablet twice daily with food (as per physicians prescription)
Storage Conditions Store at room temperature (below 30 C), protected from moisture & light

4. Therapeutic Uses

  • HIV-1 Infection (in combination with other antiretrovirals):

    • First-line therapy in treatment-experienced patients.

    • Option for treatment-nave patients depending on regimen chosen.

  • Helps in reducing viral load and increasing CD4 cell counts, improving immune function.


5. Side Effects

Common:

  • Nausea, vomiting, diarrhea

  • Abdominal pain

  • Headache, dizziness

  • Rash, itching

  • Fatigue

Serious / Severe:

  • Severe skin reactions (Stevens-Johnson syndrome, TEN rare)

  • Hepatotoxicity (jaundice, elevated liver enzymes)

  • Hyperglycemia, insulin resistance

  • Lipid abnormalities (high cholesterol, triglycerides)

  • Pancreatitis (rare)

  • Cardiac conduction abnormalities (PR interval prolongation)


6. Precautions

  • Drug Interactions: Avoid concomitant use with drugs highly dependent on CYP3A4 (e.g., simvastatin, lovastatin, rifampicin, midazolam).

  • Liver Function: Monitor regularly; contraindicated in severe hepatic impairment.

  • Allergy: Contraindicated in patients with known hypersensitivity to sulfonamides (Darunavir has a sulfonamide moiety).

  • Pregnancy & Breastfeeding: Use with caution; breastfeeding not recommended in HIV-positive mothers.

  • Metabolic Monitoring: Monitor blood glucose and lipid profile during long-term therapy.

  • Adherence: Must be taken consistently with food for optimal absorption and to prevent resistance.

Tell us about your requirement
product

Price:  

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
मोबाइल number

Email

एचआईवी विरोधी दवा अन्य उत्पाद



Back to top